Nike Surges on Strong Third Quarter

Michael Teague |

Nike Surges on Strong Third QuarterApparel giant Nike (NKE) could be setting up for a big day after reporting strong third quarter numbers.

Net income for Q3, up 55 percent on strong sales numbers in North America, was $866 million, $0.73 cents per share, on sales of $6.19 billion, compared to the prior year period’s $560 million, or $0.61 cents per share on sales of $6.2 billion against analyst estimates of $0.67 cents per share.

Global orders for March to July of this year were up 6 percent on the prior year period, while in North America, orders were up 11 percent.  The strong domestic performance, with sales up 18 percent to $2.55 billion, is seen as the result of the company shedding brands that were lagging such as Umbro.

China, where the company is still having some difficulty with sales down 9 percent to $635 million, future orders were up 4 percent, while in Europe orders were down 5 percent, a figure being attributed in part to the economic instability currently roiling the continent.

Nike continues to make the bulk of its revenue, 40 percent, from North America, and could potentially see an uptick in sales of its yoga-wear if it can manage to capitalize on Lululemon’s (LULU) product quality issues that have forced that company to recall its incredibly popular line of yoga pants this week.

The athletic apparel producer was down 2.24 percent to $53.60 per share in regular trading prior to the news, but late trading saw shares spike 8.21 percent to $58.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
LULU lululemon athletica inc. 65.19 -0.54 -0.82 1,523,003
MDCO The Medicines Company 40.45 -1.05 -2.53 902,911
NKE Nike Inc. 55.15 -0.26 -0.47 8,924,201

Comments

Emerging Growth

InMed Pharmaceuticals Inc.

InMed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.…

Private Markets

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

Snapwire

A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.